AMALTHEA: A prospective, single-arm study of the Hellenic Cooperative Oncology Group evaluating the efficacy and safety of 1st line FOLFIRI+Aflibercept in patients with metastatic colorectal cancer

Authors :: Georgios Pentheroudakis
Ioannis Efstratiou
Dimitris Bafaloukos
G Koumakis
C Petraki
Ioannis Souglakos
Emily Daskalaki
G. Fountzilas
D.G. Pectasides
Epaminontas Samantas
Eleni Vrettou
Georgia-Angeliki Koliou
Vasiliki Kotoula
Ioannis Tikas
Vasilios Karavasilis
Christos Poulios
Gerassimos Aravantinos
Source :: Annals of Oncology. 28:v176
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.

Subjects :: Oncology
medicine.medical_specialty
business.industry
Colorectal cancer
Hematology
medicine.disease
Internal medicine
FOLFIRI
Medicine
In patient
business
Single Arm Study
Aflibercept
medicine.drug

Tools